About

Bioproduction is complex particularly during cell expansion in bioreactors. Current methods to assess the viability, density and shape of mammalian cells are highly manual and require recurrent sampling. The C-Netics enables non-destructive and label-free analysis in real time. It works coupled to a dedicated single use kit that integrates an analysis cassette with high-end microelectronic sensors. The monitoring can then be run automatically during the entire duration of the cell culture.This allows the detection of anomalies in real-time and can also be used to quickly optimize a process development. About Ceidos Ceidos offers an automatic laboratory device that improves the biopharmaceutical production process. Faced with the challenge of slow, manual control of cell cultures, Ceidos introduces the C-Netics, a sophisticated device compatible with most bioreactors. It enables automated, real-time cell culture analysis with a single-use kit, increasing efficiency, reducing contamination and guaranteeing high-quality results, revolutionizing laboratory work and setting new standards in the field of biotechnology. Ceidos SA is a pioneering biotechnology company based in Monthey, Switzerland and founded in 2019. Specializing in the development of innovative solutions for the biopharmaceutical industry, Ceidos is expert in advanced technologies such as microscopy, microelectronics, and machine learning allowing the development of breakthrough bioprocessing devices. About Ceidos Ceidos offers an automatic laboratory device that improves the biopharmaceutical production process. Faced with the challenge of slow, manual control of cell cultures, Ceidos introduces the C-Netics, a sophisticated device compatible with most bioreactors. It enables automated, real-time cell culture analysis with a single-use kit, increasing efficiency, reducing contamination and guaranteeing high-quality results, revolutionizing laboratory work and setting new standards in the field of biotechnology. Ceidos SA is a pioneering biotechnology company based in Monthey, Switzerland and founded in 2019. Specializing in the development of innovative solutions for the biopharmaceutical industry, Ceidos is expert in advanced technologies such as microscopy, microelectronics, and machine learning allowing the development of breakthrough bioprocessing devices. Ceidos aims to revolutionize biopharmaceutical production with C-Netics, an advanced system for real-time, non-destructive cell culture monitoring. By integrating microscopy, dielectrophoresis, and AI-driven analysis, C-Netics ensures precise control of cell viability, density, and culture conditions. Unlike traditional methods, it connects directly to bioreactors, minimizing contamination risks and reducing manual interventions. Ceidos collaborates with industry leaders and CMOs/CDMOs to optimize bioprocesses, enhance efficiency, and improve the scalability of advanced therapies like CAR-T and monoclonal antibodies.